Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A

Abstract Background Ovarian cancer (OC) is a gynecological malignancy with a high mortality. Cisplatin-based treatment is the typical treatment regimen for OC patients; however, it may cause unfavorable resistance. The current study intends to explore the function of cancer-associated fibroblast (CA...

Full description

Bibliographic Details
Main Authors: Hua Guo, Chunfang Ha, Hui Dong, Zhijuan Yang, Yuan Ma, Yonghui Ding
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-019-1051-3
id doaj-d8701a29343b4b0f8a344cee61b4c4cd
record_format Article
spelling doaj-d8701a29343b4b0f8a344cee61b4c4cd2020-12-20T12:14:56ZengBMCCancer Cell International1475-28672019-12-0119111510.1186/s12935-019-1051-3Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1AHua Guo0Chunfang Ha1Hui Dong2Zhijuan Yang3Yuan Ma4Yonghui Ding5Department of Gynecology, General Hospital of Ningxia Medical UniversityDepartment of Gynecology, General Hospital of Ningxia Medical UniversityScientific Research Equipment Management Center, General Hospital of Ningxia Medical UniversityDepartment of Gynecology, General Hospital of Ningxia Medical UniversityDepartment of Gynecology, General Hospital of Ningxia Medical UniversityDepartment of Gynecology, General Hospital of Ningxia Medical UniversityAbstract Background Ovarian cancer (OC) is a gynecological malignancy with a high mortality. Cisplatin-based treatment is the typical treatment regimen for OC patients; however, it may cause unfavorable resistance. The current study intends to explore the function of cancer-associated fibroblast (CAF)-derived exosomal microRNA-98-5p (miR-98-5p) in cisplatin resistance in OC, and the participation of CDKN1A. Methods Bioinformatics analysis was employed in order to obtain cisplatin resistance-related differential genes in OC as well as possible upstream regulatory miRs. After gain- and loss-of-function assays in OC cells, RT-qPCR and western blot analysis were employed to measure CDKN1A and miR-98-5p expression. Dual luciferase reporter assay was applied to verify the targeting relationship between miR-98-5p and CDKN1A. CAFs were treated with miR-98-5p inhibitor, and then exosomes were isolated and co-cultured with OC cells. CCK-8, colony formation and flow cytometry assays were conducted to assess cell proliferation, cell colony formation, cell cycle distribution and cell apoptosis, respectively. At last, xenograft tumor in nude mice was carried out to test whether exosomal miR-98-5p could affect cisplatin resistance in OC in vivo. Results CDKN1A was highly expressed in cisplatin-sensitive OC cell lines, and silencing CDKN1A significantly promoted proliferation and cell cycle entry but decreased apoptosis in cisplatin-sensitive OC cells. miR-98-5p targeted CDKN1A to inhibit CDKN1A expression. CAF-derived exosomal miR-98-5p increased OC cell proliferation and cell cycle entry, but suppressed cell apoptosis. Furthermore, exosomal miR-98-5p promoted cisplatin resistance and downregulated CDKN1A in nude mice. Conclusion Collectively, CAF-derived exosomes carrying overexpressed miR-98-5p promote cisplatin resistance in OC by downregulating CDKN1A.https://doi.org/10.1186/s12935-019-1051-3Cancer-associated fibroblastsExosomesmicroRNA-98-5pCDKN1AOvarian cancerCisplatin resistance
collection DOAJ
language English
format Article
sources DOAJ
author Hua Guo
Chunfang Ha
Hui Dong
Zhijuan Yang
Yuan Ma
Yonghui Ding
spellingShingle Hua Guo
Chunfang Ha
Hui Dong
Zhijuan Yang
Yuan Ma
Yonghui Ding
Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
Cancer Cell International
Cancer-associated fibroblasts
Exosomes
microRNA-98-5p
CDKN1A
Ovarian cancer
Cisplatin resistance
author_facet Hua Guo
Chunfang Ha
Hui Dong
Zhijuan Yang
Yuan Ma
Yonghui Ding
author_sort Hua Guo
title Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
title_short Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
title_full Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
title_fullStr Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
title_full_unstemmed Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A
title_sort cancer-associated fibroblast-derived exosomal microrna-98-5p promotes cisplatin resistance in ovarian cancer by targeting cdkn1a
publisher BMC
series Cancer Cell International
issn 1475-2867
publishDate 2019-12-01
description Abstract Background Ovarian cancer (OC) is a gynecological malignancy with a high mortality. Cisplatin-based treatment is the typical treatment regimen for OC patients; however, it may cause unfavorable resistance. The current study intends to explore the function of cancer-associated fibroblast (CAF)-derived exosomal microRNA-98-5p (miR-98-5p) in cisplatin resistance in OC, and the participation of CDKN1A. Methods Bioinformatics analysis was employed in order to obtain cisplatin resistance-related differential genes in OC as well as possible upstream regulatory miRs. After gain- and loss-of-function assays in OC cells, RT-qPCR and western blot analysis were employed to measure CDKN1A and miR-98-5p expression. Dual luciferase reporter assay was applied to verify the targeting relationship between miR-98-5p and CDKN1A. CAFs were treated with miR-98-5p inhibitor, and then exosomes were isolated and co-cultured with OC cells. CCK-8, colony formation and flow cytometry assays were conducted to assess cell proliferation, cell colony formation, cell cycle distribution and cell apoptosis, respectively. At last, xenograft tumor in nude mice was carried out to test whether exosomal miR-98-5p could affect cisplatin resistance in OC in vivo. Results CDKN1A was highly expressed in cisplatin-sensitive OC cell lines, and silencing CDKN1A significantly promoted proliferation and cell cycle entry but decreased apoptosis in cisplatin-sensitive OC cells. miR-98-5p targeted CDKN1A to inhibit CDKN1A expression. CAF-derived exosomal miR-98-5p increased OC cell proliferation and cell cycle entry, but suppressed cell apoptosis. Furthermore, exosomal miR-98-5p promoted cisplatin resistance and downregulated CDKN1A in nude mice. Conclusion Collectively, CAF-derived exosomes carrying overexpressed miR-98-5p promote cisplatin resistance in OC by downregulating CDKN1A.
topic Cancer-associated fibroblasts
Exosomes
microRNA-98-5p
CDKN1A
Ovarian cancer
Cisplatin resistance
url https://doi.org/10.1186/s12935-019-1051-3
work_keys_str_mv AT huaguo cancerassociatedfibroblastderivedexosomalmicrorna985ppromotescisplatinresistanceinovariancancerbytargetingcdkn1a
AT chunfangha cancerassociatedfibroblastderivedexosomalmicrorna985ppromotescisplatinresistanceinovariancancerbytargetingcdkn1a
AT huidong cancerassociatedfibroblastderivedexosomalmicrorna985ppromotescisplatinresistanceinovariancancerbytargetingcdkn1a
AT zhijuanyang cancerassociatedfibroblastderivedexosomalmicrorna985ppromotescisplatinresistanceinovariancancerbytargetingcdkn1a
AT yuanma cancerassociatedfibroblastderivedexosomalmicrorna985ppromotescisplatinresistanceinovariancancerbytargetingcdkn1a
AT yonghuiding cancerassociatedfibroblastderivedexosomalmicrorna985ppromotescisplatinresistanceinovariancancerbytargetingcdkn1a
_version_ 1724376874910482432